Method for producing food composition that exhibits a relaxing effect by olfactory stimulation

A food composition with DMHF as a relaxing agent addresses the lack of such products by inducing a relaxing effect through olfactory stimulation, alleviating anger, fatigue, and tension, and improving peripheral circulation.

JP7591844B2Active Publication Date: 2024-11-29THE KITASATO INSTITUTE
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2023189952
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-11-07
Publication Date
2024-11-29
Estimated Expiration
2037-07-24

AI Technical Summary

Technical Problem

There is a lack of food compositions that utilize the physiological effects induced by smelling 2,5-dimethyl-4-hydroxy-3(2H)-furanone (DMHF) to provide a relaxing effect on humans and pets.

Method used

A food composition containing DMHF as a relaxing agent, which activates parasympathetic nerve activity by suppressing sympathetic nerve activity, thereby inducing a relaxing effect.

Benefits of technology

The food composition effectively alleviates psychological feelings of anger, fatigue, and tension, improves peripheral circulation, and stabilizes mood through olfactory stimulation, as demonstrated by electrophysiological and subjective mood evaluations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007591844000002
    Figure 0007591844000002
  • Figure 0007591844000003
    Figure 0007591844000003
  • Figure 0007591844000004
    Figure 0007591844000004
Patent Text Reader

Abstract

To provide a food composition for reducing the amount of HbO2 in channels 1, 4, 6, and 7 of the prefrontal cortex.SOLUTION: A food composition according to the present invention comprises 2,5-dimethyl-4-hydroxy-3(2H)-furanone; in a specific one example, comprising a Maillard reaction product obtained by dissolving glycine and glucose in a 0.25% sodium carbonate solution so that each has a final concentration of 1 mol / l, and adjusting the pH to 9 with a 10 N sodium hydroxide solution, followed by heating at 90°C for 30 minutes.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a food composition containing 2,5-dimethyl-4-hydroxy-3(2H)-furanone (DMHF). More specifically, the present invention relates to the use of DMHF, which has a relaxing effect due to olfactory stimulation. [Background technology]

[0002] DMHF has an aroma reminiscent of sweet cotton candy, ripe fruit, caramel, etc. Therefore, it is currently used as a compounding material for flavors and fragrances such as pineapple, strawberry, and raspberry, and is also used as a material for sugar flavors (Non-Patent Document 1). However, no human foods have been reported that utilize the physiological effects induced by smelling the aroma of DMHF. [Prior art documents] [Non-patent literature]

[0003] [Non-Patent Document 1] Comprehensive Fragrance Dictionary, edited by the Japan Fragrance Association, published by Asakura Publishing (1998) Summary of the Invention [Problem to be solved by the invention]

[0004] An object of the present invention is to provide a food composition that induces a relaxing effect in a subject (human or pet) through olfactory stimulation. [Means for solving the problem]

[0005] That is, in one aspect, the present invention is a relaxant containing DMHF. The present invention is also a food composition for relaxing humans or pets, containing such a relaxant. Furthermore, the present invention is use of a relaxant containing DMHF for the manufacture of a food composition. In another aspect, the present invention is a food composition for reducing the amount of HbO2 in channels 1, 4, 6 and 7 in the prefrontal cortex, containing 2,5-dimethyl-4-hydroxy-3(2H)-furanone. Effect of the Invention

[0006] According to the present invention, it is possible to provide a relaxant that can bring about a relaxing effect on subjects such as humans and pets by activating parasympathetic nervous activity with DMHF, as well as a food composition for relaxation that contains such a relaxant. [Brief description of the drawings]

[0007] [Figure 1] Rats under urethane anesthesia were exposed to DMHF odor for 10 minutes, and renal sympathetic nerve activity (RSNA, Fig. 1A) and gastric vagal nerve activity (GVNA, Fig. 1B) were measured electrophysiologically for a total of 60 minutes, starting from 50 minutes after the end of exposure. GVNA was significantly (p<0.0005) suppressed in the DMHF-exposed group compared to the control group, and GVNA was significantly (p<0.0005) promoted in the DMHF group compared to the control group. DMHF induces sedation (relaxation) by suppressing sympathetic nerve activity and favoring parasympathetic nerve activity. [Diagram 2]The subjective mood of humans after inhaling DMHF aroma was evaluated using the Profile of Mood States (POMS), and it was shown that the scores for "anger-hostility" (AH), "fatigue-bewilderment" (FI), and "tension-anxiety" (TA) after inhaling DMHF were significantly reduced compared to the scores before inhaling DMHF. This indicates that the relaxing effect of DMHF reduces psychological feelings of anger and physical feelings of fatigue and tension. The evaluation items in the figure are "anger-hostility (AH)," "confusion-bewilderment (CB)," "depression-dejection (DD)," "fatigue-inertia (FI)," "tension-anxiety (TA)," "vigor-activity (VA)," and "friendliness (F)." [Diagram 3] The miosis rate and peripheral skin temperature, which are indicators of human autonomic nervous activity due to inhalation of DMHF aroma, were shown. A significant increase in the miosis rate (Fig. 3A) after smelling DMHF (p<0.0001) suggested the possibility of increased parasympathetic nervous activity. A significant increase in peripheral skin temperature (Fig. 3B) was also confirmed (p<0.0001), indicating that inhalation of the DMHF aroma suppressed sympathetic nervous activity and increased parasympathetic nervous activity, inducing a relaxing effect. DMHF inhalation was also shown to improve peripheral circulatory function in the fingertips and other areas. BEST MODE FOR CARRYING OUT THEINVENTION

[0008] The relaxant of the present invention comprises 2,5-dimethyl-4-hydroxy-3(2H)-furanone (DMHF).

[0009] DMHF is called Furaneol (registered trademark of Firmenich) and is a flavoring ingredient that is currently widely used in many countries as a flavoring agent for food and cosmetics. This flavoring ingredient was first reported in 1960 as a product of the Maillard reaction, a non-enzymatic browning reaction that occurs during the processing of foods containing amino compounds and sugars (Hodge, JE, 1960, Novel reductones and methods of making them US Patent 2,936,308. 10 thMay.) In 1965, it was discovered as a characteristic aroma component of strawberries, and it was also found to exist in natural products (Willhalm, B., Stoll, M., Thomas, AF, 1965, 2,5-Dimethyl-4-hydroxy-2,3-dihydrofuran-3-one. Chem. Ind., 38:1629-1630.). It was subsequently isolated from various fresh foods such as pineapple, tomato, and grapes, as well as from processed foods such as roasted coffee, bread crusts, and soy sauce, and is an aroma component that characterizes those foods. (Robin, JO, Himel, CM, Silverstein, RM, Leeper, RW, Gortner WA, 1965, Volatile flavor and aroma components of pineapple. Isolation and tentative identification of 2,5-dimethyl-4-hydroxy-3(2H)-furanone. J. Food Sci., 30:280-285.;Buttery. RG, Takeoka, GR, Krammer, GE, Ling, LC, 1994, Identification of 2,5-dimethyl-4-hydroxy-3(2H)-furanone in fresh and processed tomato. Lebensm. Wiss. Technol., 27:592-594.;Rapp, A., Knipser, W., Engel, L., Ullemeyer, H., Heimann, W., 1978, Off-flavor compounds in the berry and wine aroma of grapevine hybrids.I. The strawberry-like aroma. varieties. II. Z.Lebensm. Unters. Forsch., 167:111-114.;Schieberle, P., 1990, Studies on bakers yeast as source of Maillard type bread flavor compounds. In The Maillard Reaction in Food Processing, Human Nutrition and Physiology; Finot, PA, Aeschbacher, HU, Hurrell, RF, Liardon, R., Eds., Birkhauser, Basel, Swizerland, 1990,187-196.;Steinhaus, P., Schieberle, P., 2007, Characterization of the key aroma compounds in soy sauce using approaches of molecular sensory science. J. Agric. Food Chem., 38:2329-2336.).

[0010] DMHF is a colorless or white crystal, slightly soluble in water, and soluble in alcohol and oil. It is unstable at room temperature and decomposes gradually. The threshold is low at 0.04 ppm. It is usually synthesized from 3,5-dioxo-2,5-hexanediol or its ester (Non-Patent Document 1).

[0011] The present invention is based on the discovery that the aroma of DMHF acts on the autonomic nervous system via the olfactory system, suppressing sympathetic nervous activity and making parasympathetic nervous activity significant, resulting in a relaxing effect. It has been found that inhaling the aroma of DMHF reduces anger, fatigue, and tension in a subjective mood assessment in humans, and also increases peripheral skin temperature, which has been shown to improve peripheral circulatory function. That is, the inventors have found that inhaling the aroma of DMHF not only produces a relaxing effect in humans and animals such as pets, but also has the effects of easing anger, reducing or easing fatigue, easing tension, easing stress, improving peripheral circulation, and stabilizing the mind.

[0012] The physiological effects of aroma components of food and plant essential oils refer to the fact that aroma components affect the autonomic nervous system, central nervous system, and endocrine system, and bring about various effects such as stress reduction, improved concentration, improved sleep, and improved work efficiency. There have been many research reports on the mechanism of such physiological effects, and there are mainly two routes. One is the route in which aroma components are taken into the body (bloodstream), and the other is the route via the olfactory nervous system. In the former, the aroma components contained in essential oils are absorbed through the skin by massage using essential oils, absorbed into the alveoli during breathing and taken into the bloodstream through the lung mucosa, or taken orally and naturally digested and absorbed into the bloodstream. It is thought that it takes at least 20 minutes for aroma components to be taken into the bloodstream, reach the brain, and produce physiological effects (Easy Essential Oil Chemistry for Learning Aromatherapy, by E. Joy Bowles, published by Fragrance Journal Inc. (2002)). On the other hand, the latter is a route in which aroma components flow into the nasal cavity with breathing, or from the posterior nasal cavity during chewing of food, bind to receptors present on the surface of olfactory cells, and the binding information is projected from the axon to the olfactory bulb and reaches deep areas of the brain such as the limbic system. In this case, the hypothalamus in the limbic system controls the autonomic nervous system, endocrine system, and immune system in an integrated manner, and thus affects these activities, inducing physiological effects such as sedation and excitement. The time it takes for physiological effects to appear is very short, and can be seen in just a few minutes. The present invention relies on the latter route.

[0013] The relaxant of the present invention may contain only DMHF, which is an active ingredient, or may further contain other ingredients. The other ingredients may be any ingredients that do not interfere with the action of the active ingredient and are acceptable as food. For example, minerals, vitamins, flavonoids, quinones, polyphenols, amino acids, nucleic acids, essential fatty acids, cooling agents, binders, sweeteners, disintegrants, lubricants, colorants, flavors, stabilizers, preservatives, sustained release regulators, surfactants, dissolving agents, or wetting agents may be mentioned.

[0014] The food composition for human or pet relaxation of the present invention contains the relaxant of the present invention, and when ingested by a human or pet, the aroma components flow into the nasal cavity, or the aroma components flow from the postnasal cavity during chewing of food, resulting in a relaxing effect and a tranquilizing effect. Therefore, the food composition is not particularly limited as long as the aroma components flow into the nasal cavity when ingested, or the aroma components flow into the nasal cavity during chewing. Examples of such food compositions include supplements, candies, chewing gums, caramels, Ramune, gummies, tablets, soft drinks, tea, and coffee. The food composition for relaxation of the present invention can be produced by adding DMHF during or after the preparation of these food compositions.

[0015] The amount of the active ingredient in the relaxant and food composition is not particularly limited, but the concentration can be 2.5 mg / l to 100 mg / l, preferably 50 mg / l to 60 mg / l for humans. Also, the concentration can be 0.25 mg / l to 10 mg / l, preferably 5 mg / l to 6 mg / l for pets. By setting the concentration within such a range, the relaxant and food composition can exert the desired effect when ingested.

[0016] When the food composition is a supplement, it may be in the form of an orally disintegrating tablet, a chewable tablet, a granule, or an oral liquid. In addition to the active ingredient, ingredients acceptable for use as a supplement may be added.

[0017] The present invention relates to the use of a relaxant containing DMHF for the production of a food composition. By using a relaxant containing DMHF in the production of a food composition, a food composition having a tranquilizing effect due to its relaxing action can be obtained.

[0018] The present invention will be described below with reference to examples. Note that the following examples are given for the purpose of explaining the present invention, and are not intended to limit the present invention. EXAMPLES

[0019] Example 1 (Measurement of DMHF concentration in heat-processed foods) As a model of heat-processed food, glycine and glucose were heated. More specifically, glycine and glucose were dissolved in 0.25% sodium carbonate aqueous solution to a final concentration of 1 mol / l each, and the solution was adjusted to pH 9 with 10N sodium hydroxide aqueous solution, and heated at 90°C for 30 minutes to cause the Maillard reaction to produce a Maillard sample. 25 ml of this Maillard sample was mixed with 25 ml of distilled water, and methyl decanoate (final concentration 0.5 mg / l) was added as an internal standard substance. The mixture was passed through a glass column packed with 5.0 g of Tenax TA resin, a porous polymer, to adsorb the aroma components onto the Tenax TA resin, and then eluted with 100 ml of a mixed solvent of pentane and diethyl ether in a 1:1 ratio. The resulting extract was thoroughly dehydrated with anhydrous sodium sulfate, and the volatile fraction was then reliably obtained using the Solvent Assisted Flavor Evaporation method (Engel, W., Bahr, W., Schieberle, P., 1999, Solvent assisted flavour evaporation - a new and versatile technique for the careful and direct isolation of aroma compounds from complex food matrices. Eur. Food Res. Tecnol., 209:237-241.). The solvent in the volatile fraction was then distilled off under a nitrogen stream to obtain an aroma concentrate.

[0020] The obtained aroma concentrate was subjected to gas chromatography-olfactometry (GC-O) analysis. The model used was Gas Chromatography GC-2010 Plus (Shimadzu Corporation) connected to a sniffer-9000 (Brechbuhler). The capillary column used was BD-Wax (J&W), with dimensions of 60 m (length) x 0.25 mm (inner diameter) x 0.25 μm (film thickness). Pure helium was used as the carrier gas and makeup gas. The sample injection port and detector temperatures were both set to 210°C. The temperature rise program was to hold at 40°C for 10 minutes, then raise the temperature to 210°C at 3°C ​​per minute, and hold the temperature at 210°C for 30 minutes. The amount of aroma concentrate injected into the GC-O was 0.5 μl.

[0021] The aroma components with high contributions were identified by the aroma extract dilution analysis (AEDA) method (Heuchert, JP, McNair, DM, translated by Yokoyama Kazuhito, 2015). That is, the aroma concentrate was prepared by diluting it stepwise with diethyl ether, and GC-O analysis was performed starting from the lowest dilution ratio. The retention time and the fragrance tone at which the odor was detected were recorded, and the analysis was continued until the odor was no longer detected. The dilution ratio at which the odor was finally detected was taken as the flavor dilution factor (FD-factor) of the odor, and the FD-factor was calculated for all odors. The higher the FD-factor, the higher the contribution to the odor. Next, the aroma components with high FD-factors were identified by Gas Chromatography-Mass Spectrometry (GC-MS). The GC-MS model used was GC-MS QP-2010 (Shimadzu Corporation). The analysis conditions were the same as those for GC-O. The library used was Wiley. As a result, it was concluded that DMHF had the highest FD-factor of 4^6, and contributed greatly to the aroma of the Maillard sample. A calibration curve for DMHF concentration was created, giving DMHF concentration (mg / l) = [(GC peak area of ​​DMHF / GC peak area of ​​internal standard substance) - 0.0558] / 23.497 (r^2 = 1.00), and the DMHF concentration in the Maillard sample calculated from this calibration curve was 57.72mg / l. Example 2 (Evaluation of autonomic nervous activity in rats by DMHF odor stimulation)

[0022] Using DMHF at a concentration 1 / 10 that obtained in Example 1 (5.7 mg / l), rats were exposed to the aroma and sympathetic and parasympathetic nerve activities were measured. More specifically, the procedure is as follows. Six male Wistar rats were pre-bred for one week under conditions of a 12-hour light period and a 12-hour dark period, and after fasting for three hours at 9 weeks of age, they were anesthetized with urethane using an aqueous urethane solution (1 g / kg BW) and abdominally opened. The renal sympathetic nerve efferent branch or gastric vagus nerve efferent branch was isolated and exposed, and the efferent branch was cut, and the nerve filament was isolated from the central side and suspended with a silver recording electrode, and the electrical activity of the nerve was measured. 10ml of DMHF (5.7mg / l) at one-tenth the concentration obtained in Example 1 was soaked in absorbent cotton measuring 4cm long, 4cm wide, and 1cm thick, and placed on the bottom of a beaker-like plastic container. The mouth of the container was placed over the rats' nasal cavity to expose them to the aroma for 10 minutes, and the electrical activity of each nerve was measured. The group was the aroma exposure group, and the control group was the control group, in which the same absorbent cotton was soaked in 10ml of distilled water, exposed in the same manner, and the electrical activity of each nerve was measured. The changes in autonomic nerve activity were measured electrophysiologically for a total of 60 minutes, 10 minutes during exposure and 50 minutes after exposure. The data on autonomic nerve activity was analyzed using the average value of the firing frequency per 5 seconds (pulse / 5s) every 5 minutes. The time period immediately after the start was set to 100%, and the changes over time were expressed as a percentage. As a result, renal sympathetic nerve activity was gradually suppressed from 10 to 25 minutes after the start of exposure, and the suppressed state continued until the end of measurement, with a significant difference from the control group (p<0.0005). On the other hand, gastric parasympathetic nerve activity was gradually promoted from 10 to 40 minutes after the start of exposure, and the promoted state continued until the end of measurement, with a significant difference from the control group (p<0.0005). From the above, it was concluded that the aroma stimulation of DMHF suppresses renal sympathetic nerve activity and promotes gastric parasympathetic nerve activity in rats. Example 3 (Evaluation of human subjective mood after inhaling DMHF odor)

[0023] The subjective mood of humans was evaluated when inhaling the aroma of DMHF at the concentration obtained in Example 1. More specifically, the procedure is as follows. Twenty-six men and women (13 men and 13 women) aged between 20 and 27 were selected as panelists, and changes in mood were evaluated before and after sniffing the aroma of DMHF using the Profile of Mood States 2nd edition (POMS) (Non-Patent Document 22 POMS 2 Japanese Version Manual, p. 1-2, Kaneko Shobo). POMS is a widely used questionnaire that can capture changes in subjective mood and emotions, and consists of seven evaluation items: anger-hostility (AH), confusion-bewilderment (CB), depression-dejection (DD), fatigue-inertia (FI), tension-anxiety (TA), vigor-activity (VA), and friendliness (F). The scale is defined as a 16-point scale: 0 = not at all, 3 = a little, 6 = a fair amount, 9 = quite a lot, 15 = a great deal, and the evaluation scores for each evaluation item were recorded as data. The results showed that the evaluation scores for "anger-hostility" (AH), "fatigue-lethargy" (FI), and "tension-anxiety" (TA) were significantly reduced compared to before sniffing DMHF (p<0.05), and it was concluded that inhaling the aroma of DMHF relieves feelings of anger, fatigue, and tension. Example 4 (Evaluation of human autonomic nervous and cerebral activity following inhalation of DMHF odor)

[0024] Human autonomic nerve activity was evaluated when the aroma of DMHF at the concentration obtained in Example 1 was inhaled. More specifically, the procedure is as follows. 10 ml of DMHF at the concentration obtained in Example 1 was dispensed into brown vials, and equilibrated at room temperature for 30 minutes. The aroma was filled in the head space, and presented to panelists. While inhaling the aroma for 2 minutes under natural breathing, the constriction rate (CR) calculated from the pupil diameter before light irradiation and the minimum pupil diameter after light irradiation was measured using a constriction measuring device. Furthermore, the DMHF aroma was inhaled for 2 minutes under natural breathing, and the temperature of the fingertip of the index finger of the panelist's dominant hand was measured as the peripheral skin temperature using a thermosensor, and the temperature difference before and after DMHF inhalation was calculated. As a result, CR and peripheral skin temperature increased significantly (both p<0.00001) due to DMHF inhalation. Miosis occurs due to contraction of the pupillary sphincter, which is controlled by the parasympathetic nervous system, or relaxation of the pupillary dilator, which is controlled by the sympathetic nervous system; in a sedated state, the parasympathetic nervous system predominates, increasing the rate of miosis, while when the sympathetic nervous system predominates, the rate of pupil constriction decreases because the pupil dilation rate after miosis increases. On the other hand, because peripheral blood vessels are controlled only by the sympathetic nervous system, suppression of sympathetic nervous activity causes peripheral blood vessels to expand, increasing blood flow and raising skin temperature. From the above, it was concluded that inhaling the aroma of DMHF suppresses sympathetic nervous activity in humans, causing the parasympathetic nervous system to predominate, inducing a state of sedation.

[0025] Furthermore, human cerebral activity was evaluated when the aroma of DMHF at the concentration obtained in Example 1 was inhaled. More specifically, the procedure is as follows. A holder with a near-infrared emitting probe and a light receiving probe arranged at 3 cm intervals was attached to the forehead of the panelist according to the 10 / 20 electrode arrangement method. The wavelengths of the near-infrared rays were 840 nm and 770 nm, and the number of measurement channels was 16. After attaching the probe, the amount of oxygenated hemoglobin (HbO2) in the frontal lobe at rest for 2 minutes was measured and used as a control. Then, 10 ml of DMHF at the concentration obtained in Example 1 was dispensed into brown vials, equilibrated at room temperature for 30 minutes, and the aroma was filled in the head space. The panelist was presented with the aroma inhaled for 2 minutes and the change in the amount of HbO2 was continuously measured. The results are shown in Table 1. Cerebral activity was evaluated by grasping the dynamics of HbO2 in the frontal lobe. When the cerebrum is actively active, the amount of HbO2 is high, and when it is in a sedated state, the amount of HbO2 is low. When the difference between the HbO2 amount (mM-mm) in the control group and the HbO2 amount (mM-mm) after DMHF inhalation was calculated, it was found to have significantly decreased in all 16 channels in the prefrontal cortex, which confirmed a significant calming of cerebral activity. In particular, the decrease in HbO2 amount was remarkable in channels 4, 6, and 7 near the full central part of the prefrontal cortex, and it was concluded that cerebral activity was calmed overall, centered on the full central part of the prefrontal cortex.

[0026] [Table 1]

[0027] From the results obtained in Examples 1 to 4, it was concluded that DMHF not only suppresses sympathetic nervous activity and promotes parasympathetic nervous activity in animals, thereby inducing sedation, but also suppresses sympathetic nervous activity in humans and acts on higher central nervous activity, thereby bringing about a sedative effect on the living body and influencing mood and emotions.

[0028] The present invention includes the following aspects. (1) A food composition for reducing the amount of HbO2 in channels 1, 4, 6 and 7 in the prefrontal cortex, comprising 2,5-dimethyl-4-hydroxy-3(2H)-furanone. (2) A food composition for reducing the amount of HbO2 in channels 1, 4, 6 and 7 in the prefrontal cortex, comprising a Maillard reaction product obtained by dissolving glycine and glucose in 0.25% aqueous sodium carbonate solution to a final concentration of 1 mol / l each, adjusting the pH to 9 with 10N aqueous sodium hydroxide solution, and heating the solution at 90°C for 30 minutes, wherein the food composition contains 50 mg / l to 60 mg / l of 2,5-dimethyl-4-hydroxy-3(2H)-furanone as measured by gas chromatography. (3) A food composition for reducing the amount of HbO2 in channels 1, 4, 6 and 7 in the prefrontal cortex, comprising a Maillard reaction product obtained by dissolving glycine and glucose in 0.25% aqueous sodium carbonate solution to a final concentration of 1 mol / l each, adjusting the pH to 9 with 10N aqueous sodium hydroxide solution, and heating the solution at 90°C for 30 minutes, wherein the food composition contains 5 mg / l to 6 mg / l of 2,5-dimethyl-4-hydroxy-3(2H)-furanone as measured by gas chromatography. (4) The food composition according to any one of (1) to (3) above, which is a supplement, a candy, a chewing gum, a caramel, a Ramune, a gummy, a tablet, a soft drink, tea, or coffee. (5) The food composition according to (4) above, wherein the supplement is an orally disintegrating tablet, a chewable tablet, a granule, or an oral liquid. (6) A food composition according to any one of (1) to (5) above, which is for human use. (7) A food composition according to any one of (1) to (5) above, which is for pets.

Claims

1. A method for producing a food composition that reduces the amount of HbO2 in channels 1, 4, 6 and 7 in the prefrontal cortex and exhibits a relaxing effect in response to olfactory stimulation, comprising: The method comprises dissolving glycine and glucose in a 0.25% aqueous sodium carbonate solution to a final concentration of 1 mol / l, adjusting the pH to 9 with a 10N aqueous sodium hydroxide solution, and heating the solution at 90°C for 30 minutes to obtain a Maillard reaction product (25 ml), adding 25 ml of distilled water, passing the solution through a glass column packed with 5.0 g of Tenax TA resin, allowing the Tenax TA resin to adsorb the aroma components, and then eluting the solution with 100 ml of a 1:1 mixed solvent of pentane and diethyl ether. The resulting extract is dehydrated by adding anhydrous sodium sulfate, and then the volatile fraction obtained by the Solvent Assisted Flavor Evaporation method is obtained, and further comprising distilling off the solvent of the volatile fraction under a nitrogen stream to obtain a concentrate. the food composition contains 50 mg / l to 60 mg / l of 2,5-dimethyl-4-hydroxy-3(2H)-furanone as measured by gas chromatography; A method for producing a food composition that exhibits a relaxing effect in response to olfactory stimulation, in which the reduction in HbO2 levels in channels 1, 4, 6 and 7 in the prefrontal cortex is 0.13105, 0.10445, 0.12071 and 0.1237, respectively.

2. A method for producing a food composition that exhibits a relaxing effect through olfactory stimulation as described in claim 1, wherein the reduction in HbO2 levels in channels 1, 4, 6 and 7 of the prefrontal cortex is greater than the reduction in HbO2 levels in channels 8, 11 and 14 of the prefrontal cortex.

3. 3. A method for producing a food composition that exhibits a relaxing effect through olfactory stimulation, as described in claim 1 or claim 2, wherein the food composition is a supplement, candy, chewing gum, caramel, ramune, gummy, tablet, soft drink, tea, or coffee.

4. The method for producing a food composition that exhibits a relaxing effect through olfactory stimulation, as described in claim 3, wherein the supplement is an orally disintegrating tablet, a chewable tablet, a granule, or an oral liquid.

5. A method for producing a food composition that exhibits a relaxing effect through olfactory stimulation according to any one of claims 1 to 4, for use in humans.

6. A method for producing a food composition that exhibits a relaxing effect through olfactory stimulation according to any one of claims 1 to 4, which is for use in pets.

Citation Information

Patent Citations

  • R-curcumene-based plant volatile substances

    JP2012519197A

  • Cereal tea composition

    JP2017012077A